Global Veterinary Biologics Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
LPI (LP Information)' newest research report, the “Veterinary Biologics Industry Forecast” looks at past sales and reviews total world Veterinary Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Biologics sales for 2023 through 2029. With Veterinary Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biologics industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biologics.
The global Veterinary Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary Biologics players cover Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Veterinary Biologics market?
What factors are driving Veterinary Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biologics market opportunities vary by end market size?
How does Veterinary Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
LPI (LP Information)' newest research report, the “Veterinary Biologics Industry Forecast” looks at past sales and reviews total world Veterinary Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Biologics sales for 2023 through 2029. With Veterinary Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biologics industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biologics.
The global Veterinary Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary Biologics players cover Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Vaccines
- Monoclonal Antibodies
- Llivestock
- Equine
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco/Eli Lilly
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal
What is the 10-year outlook for the global Veterinary Biologics market?
What factors are driving Veterinary Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biologics market opportunities vary by end market size?
How does Veterinary Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Biologics by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Biologics Segment by Type
2.2.1 Vaccines
2.2.2 Monoclonal Antibodies
2.3 Veterinary Biologics Sales by Type
2.3.1 Global Veterinary Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Biologics Sale Price by Type (2018-2023)
2.4 Veterinary Biologics Segment by Application
2.4.1 Llivestock
2.4.2 Equine
2.4.3 Other
2.5 Veterinary Biologics Sales by Application
2.5.1 Global Veterinary Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Biologics Sale Price by Application (2018-2023)
3 GLOBAL VETERINARY BIOLOGICS BY COMPANY
3.1 Global Veterinary Biologics Breakdown Data by Company
3.1.1 Global Veterinary Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Biologics Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Biologics Revenue by Company (2018-2023)
3.2.2 Global Veterinary Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Biologics Sale Price by Company
3.4 Key Manufacturers Veterinary Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Biologics Product Location Distribution
3.4.2 Players Veterinary Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Biologics Sales Growth
4.4 APAC Veterinary Biologics Sales Growth
4.5 Europe Veterinary Biologics Sales Growth
4.6 Middle East & Africa Veterinary Biologics Sales Growth
5 AMERICAS
5.1 Americas Veterinary Biologics Sales by Country
5.1.1 Americas Veterinary Biologics Sales by Country (2018-2023)
5.1.2 Americas Veterinary Biologics Revenue by Country (2018-2023)
5.2 Americas Veterinary Biologics Sales by Type
5.3 Americas Veterinary Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Biologics Sales by Region
6.1.1 APAC Veterinary Biologics Sales by Region (2018-2023)
6.1.2 APAC Veterinary Biologics Revenue by Region (2018-2023)
6.2 APAC Veterinary Biologics Sales by Type
6.3 APAC Veterinary Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Biologics by Country
7.1.1 Europe Veterinary Biologics Sales by Country (2018-2023)
7.1.2 Europe Veterinary Biologics Revenue by Country (2018-2023)
7.2 Europe Veterinary Biologics Sales by Type
7.3 Europe Veterinary Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Biologics by Country
8.1.1 Middle East & Africa Veterinary Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Biologics Sales by Type
8.3 Middle East & Africa Veterinary Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Biologics
10.3 Manufacturing Process Analysis of Veterinary Biologics
10.4 Industry Chain Structure of Veterinary Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Biologics Distributors
11.3 Veterinary Biologics Customer
12 WORLD FORECAST REVIEW FOR VETERINARY BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Veterinary Biologics Market Size Forecast by Region
12.1.1 Global Veterinary Biologics Forecast by Region (2024-2029)
12.1.2 Global Veterinary Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Biologics Forecast by Type
12.7 Global Veterinary Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Biologics Product Portfolios and Specifications
13.1.3 Merck Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Biologics Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Biologics Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Biologics Product Portfolios and Specifications
13.4.3 Ceva Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Biologics Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Biologics Product Portfolios and Specifications
13.6.3 HVRI Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Biologics Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Biologics Product Portfolios and Specifications
13.8.3 Yebio Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Biologics Product Portfolios and Specifications
13.9.3 DHN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Biologics Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco/Eli Lilly
13.11.1 Elanco/Eli Lilly Company Information
13.11.2 Elanco/Eli Lilly Veterinary Biologics Product Portfolios and Specifications
13.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Elanco/Eli Lilly Main Business Overview
13.11.5 Elanco/Eli Lilly Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Biologics Product Portfolios and Specifications
13.12.3 Virbac Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Biologics Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Biologics Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Biologics Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken
13.16.1 Kyoto Biken Company Information
13.16.2 Kyoto Biken Veterinary Biologics Product Portfolios and Specifications
13.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Kyoto Biken Main Business Overview
13.16.5 Kyoto Biken Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Biologics Product Portfolios and Specifications
13.17.3 FATRO Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Biologics Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Biologics Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal
13.20.1 Avimex Animal Company Information
13.20.2 Avimex Animal Veterinary Biologics Product Portfolios and Specifications
13.20.3 Avimex Animal Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Avimex Animal Main Business Overview
13.20.5 Avimex Animal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Biologics by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Biologics Segment by Type
2.2.1 Vaccines
2.2.2 Monoclonal Antibodies
2.3 Veterinary Biologics Sales by Type
2.3.1 Global Veterinary Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Biologics Sale Price by Type (2018-2023)
2.4 Veterinary Biologics Segment by Application
2.4.1 Llivestock
2.4.2 Equine
2.4.3 Other
2.5 Veterinary Biologics Sales by Application
2.5.1 Global Veterinary Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Biologics Sale Price by Application (2018-2023)
3 GLOBAL VETERINARY BIOLOGICS BY COMPANY
3.1 Global Veterinary Biologics Breakdown Data by Company
3.1.1 Global Veterinary Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Biologics Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Biologics Revenue by Company (2018-2023)
3.2.2 Global Veterinary Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Biologics Sale Price by Company
3.4 Key Manufacturers Veterinary Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Biologics Product Location Distribution
3.4.2 Players Veterinary Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Biologics Sales Growth
4.4 APAC Veterinary Biologics Sales Growth
4.5 Europe Veterinary Biologics Sales Growth
4.6 Middle East & Africa Veterinary Biologics Sales Growth
5 AMERICAS
5.1 Americas Veterinary Biologics Sales by Country
5.1.1 Americas Veterinary Biologics Sales by Country (2018-2023)
5.1.2 Americas Veterinary Biologics Revenue by Country (2018-2023)
5.2 Americas Veterinary Biologics Sales by Type
5.3 Americas Veterinary Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Biologics Sales by Region
6.1.1 APAC Veterinary Biologics Sales by Region (2018-2023)
6.1.2 APAC Veterinary Biologics Revenue by Region (2018-2023)
6.2 APAC Veterinary Biologics Sales by Type
6.3 APAC Veterinary Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Biologics by Country
7.1.1 Europe Veterinary Biologics Sales by Country (2018-2023)
7.1.2 Europe Veterinary Biologics Revenue by Country (2018-2023)
7.2 Europe Veterinary Biologics Sales by Type
7.3 Europe Veterinary Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Biologics by Country
8.1.1 Middle East & Africa Veterinary Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Biologics Sales by Type
8.3 Middle East & Africa Veterinary Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Biologics
10.3 Manufacturing Process Analysis of Veterinary Biologics
10.4 Industry Chain Structure of Veterinary Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Biologics Distributors
11.3 Veterinary Biologics Customer
12 WORLD FORECAST REVIEW FOR VETERINARY BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Veterinary Biologics Market Size Forecast by Region
12.1.1 Global Veterinary Biologics Forecast by Region (2024-2029)
12.1.2 Global Veterinary Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Biologics Forecast by Type
12.7 Global Veterinary Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Biologics Product Portfolios and Specifications
13.1.3 Merck Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Biologics Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Biologics Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Biologics Product Portfolios and Specifications
13.4.3 Ceva Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Biologics Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Biologics Product Portfolios and Specifications
13.6.3 HVRI Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Biologics Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Biologics Product Portfolios and Specifications
13.8.3 Yebio Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Biologics Product Portfolios and Specifications
13.9.3 DHN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Biologics Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco/Eli Lilly
13.11.1 Elanco/Eli Lilly Company Information
13.11.2 Elanco/Eli Lilly Veterinary Biologics Product Portfolios and Specifications
13.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Elanco/Eli Lilly Main Business Overview
13.11.5 Elanco/Eli Lilly Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Biologics Product Portfolios and Specifications
13.12.3 Virbac Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Biologics Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Biologics Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Biologics Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken
13.16.1 Kyoto Biken Company Information
13.16.2 Kyoto Biken Veterinary Biologics Product Portfolios and Specifications
13.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Kyoto Biken Main Business Overview
13.16.5 Kyoto Biken Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Biologics Product Portfolios and Specifications
13.17.3 FATRO Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Biologics Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Biologics Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal
13.20.1 Avimex Animal Company Information
13.20.2 Avimex Animal Veterinary Biologics Product Portfolios and Specifications
13.20.3 Avimex Animal Veterinary Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Avimex Animal Main Business Overview
13.20.5 Avimex Animal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccines
Table 4. Major Players of Monoclonal Antibodies
Table 5. Global Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 6. Global Veterinary Biologics Sales Market Share by Type (2018-2023)
Table 7. Global Veterinary Biologics Revenue by Type (2018-2023) & ($ million)
Table 8. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Table 9. Global Veterinary Biologics Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 11. Global Veterinary Biologics Sales Market Share by Application (2018-2023)
Table 12. Global Veterinary Biologics Revenue by Application (2018-2023)
Table 13. Global Veterinary Biologics Revenue Market Share by Application (2018-2023)
Table 14. Global Veterinary Biologics Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Veterinary Biologics Sales by Company (2018-2023) & (K Units)
Table 16. Global Veterinary Biologics Sales Market Share by Company (2018-2023)
Table 17. Global Veterinary Biologics Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Veterinary Biologics Revenue Market Share by Company (2018-2023)
Table 19. Global Veterinary Biologics Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Veterinary Biologics Producing Area Distribution and Sales Area
Table 21. Players Veterinary Biologics Products Offered
Table 22. Veterinary Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Veterinary Biologics Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Veterinary Biologics Sales Market Share Geographic Region (2018-2023)
Table 27. Global Veterinary Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Veterinary Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Veterinary Biologics Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Veterinary Biologics Sales Market Share by Country/Region (2018-2023)
Table 31. Global Veterinary Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Veterinary Biologics Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 34. Americas Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 35. Americas Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 37. Americas Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 38. Americas Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 39. APAC Veterinary Biologics Sales by Region (2018-2023) & (K Units)
Table 40. APAC Veterinary Biologics Sales Market Share by Region (2018-2023)
Table 41. APAC Veterinary Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Veterinary Biologics Revenue Market Share by Region (2018-2023)
Table 43. APAC Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 44. APAC Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 45. Europe Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 46. Europe Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 47. Europe Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 49. Europe Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 50. Europe Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Veterinary Biologics
Table 58. Key Market Challenges & Risks of Veterinary Biologics
Table 59. Key Industry Trends of Veterinary Biologics
Table 60. Veterinary Biologics Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Veterinary Biologics Distributors List
Table 63. Veterinary Biologics Customer List
Table 64. Global Veterinary Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Veterinary Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Veterinary Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Veterinary Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Veterinary Biologics Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Veterinary Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Veterinary Biologics Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Veterinary Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Veterinary Biologics Product Portfolios and Specifications
Table 80. Merck Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Zoetis Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 84. Zoetis Veterinary Biologics Product Portfolios and Specifications
Table 85. Zoetis Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Zoetis Main Business
Table 87. Zoetis Latest Developments
Table 88. Boehringer Ingelheim Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Veterinary Biologics Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Ceva Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Veterinary Biologics Product Portfolios and Specifications
Table 95. Ceva Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Ceva Main Business
Table 97. Ceva Latest Developments
Table 98. CAHIC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Veterinary Biologics Product Portfolios and Specifications
Table 100. CAHIC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. HVRI Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. HVRI Veterinary Biologics Product Portfolios and Specifications
Table 105. HVRI Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. HVRI Main Business
Table 107. HVRI Latest Developments
Table 108. Ringpu Biology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Ringpu Biology Veterinary Biologics Product Portfolios and Specifications
Table 110. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Ringpu Biology Main Business
Table 112. Ringpu Biology Latest Developments
Table 113. Yebio Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. Yebio Veterinary Biologics Product Portfolios and Specifications
Table 115. Yebio Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Yebio Main Business
Table 117. Yebio Latest Developments
Table 118. DHN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. DHN Veterinary Biologics Product Portfolios and Specifications
Table 120. DHN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. DHN Main Business
Table 122. DHN Latest Developments
Table 123. WINSUN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 124. WINSUN Veterinary Biologics Product Portfolios and Specifications
Table 125. WINSUN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. WINSUN Main Business
Table 127. WINSUN Latest Developments
Table 128. Elanco/Eli Lilly Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 129. Elanco/Eli Lilly Veterinary Biologics Product Portfolios and Specifications
Table 130. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Elanco/Eli Lilly Main Business
Table 132. Elanco/Eli Lilly Latest Developments
Table 133. Virbac Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 134. Virbac Veterinary Biologics Product Portfolios and Specifications
Table 135. Virbac Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Virbac Main Business
Table 137. Virbac Latest Developments
Table 138. Jinyu Bio-Technology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 139. Jinyu Bio-Technology Veterinary Biologics Product Portfolios and Specifications
Table 140. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Jinyu Bio-Technology Main Business
Table 142. Jinyu Bio-Technology Latest Developments
Table 143. ChengDu Tecbond Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 144. ChengDu Tecbond Veterinary Biologics Product Portfolios and Specifications
Table 145. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. ChengDu Tecbond Main Business
Table 147. ChengDu Tecbond Latest Developments
Table 148. CAVAC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 149. CAVAC Veterinary Biologics Product Portfolios and Specifications
Table 150. CAVAC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. CAVAC Main Business
Table 152. CAVAC Latest Developments
Table 153. Kyoto Biken Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoto Biken Veterinary Biologics Product Portfolios and Specifications
Table 155. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Kyoto Biken Main Business
Table 157. Kyoto Biken Latest Developments
Table 158. FATRO Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 159. FATRO Veterinary Biologics Product Portfolios and Specifications
Table 160. FATRO Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. FATRO Main Business
Table 162. FATRO Latest Developments
Table 163. Vaksindo Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 164. Vaksindo Veterinary Biologics Product Portfolios and Specifications
Table 165. Vaksindo Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Vaksindo Main Business
Table 167. Vaksindo Latest Developments
Table 168. Bio-Labs Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 169. Bio-Labs Veterinary Biologics Product Portfolios and Specifications
Table 170. Bio-Labs Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Bio-Labs Main Business
Table 172. Bio-Labs Latest Developments
Table 173. Avimex Animal Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 174. Avimex Animal Veterinary Biologics Product Portfolios and Specifications
Table 175. Avimex Animal Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Avimex Animal Main Business
Table 177. Avimex Animal Latest Developments
Table 1. Veterinary Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccines
Table 4. Major Players of Monoclonal Antibodies
Table 5. Global Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 6. Global Veterinary Biologics Sales Market Share by Type (2018-2023)
Table 7. Global Veterinary Biologics Revenue by Type (2018-2023) & ($ million)
Table 8. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Table 9. Global Veterinary Biologics Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 11. Global Veterinary Biologics Sales Market Share by Application (2018-2023)
Table 12. Global Veterinary Biologics Revenue by Application (2018-2023)
Table 13. Global Veterinary Biologics Revenue Market Share by Application (2018-2023)
Table 14. Global Veterinary Biologics Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Veterinary Biologics Sales by Company (2018-2023) & (K Units)
Table 16. Global Veterinary Biologics Sales Market Share by Company (2018-2023)
Table 17. Global Veterinary Biologics Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Veterinary Biologics Revenue Market Share by Company (2018-2023)
Table 19. Global Veterinary Biologics Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Veterinary Biologics Producing Area Distribution and Sales Area
Table 21. Players Veterinary Biologics Products Offered
Table 22. Veterinary Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Veterinary Biologics Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Veterinary Biologics Sales Market Share Geographic Region (2018-2023)
Table 27. Global Veterinary Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Veterinary Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Veterinary Biologics Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Veterinary Biologics Sales Market Share by Country/Region (2018-2023)
Table 31. Global Veterinary Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Veterinary Biologics Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 34. Americas Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 35. Americas Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 37. Americas Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 38. Americas Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 39. APAC Veterinary Biologics Sales by Region (2018-2023) & (K Units)
Table 40. APAC Veterinary Biologics Sales Market Share by Region (2018-2023)
Table 41. APAC Veterinary Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Veterinary Biologics Revenue Market Share by Region (2018-2023)
Table 43. APAC Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 44. APAC Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 45. Europe Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 46. Europe Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 47. Europe Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 49. Europe Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 50. Europe Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Veterinary Biologics Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Veterinary Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Veterinary Biologics Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Veterinary Biologics Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Veterinary Biologics
Table 58. Key Market Challenges & Risks of Veterinary Biologics
Table 59. Key Industry Trends of Veterinary Biologics
Table 60. Veterinary Biologics Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Veterinary Biologics Distributors List
Table 63. Veterinary Biologics Customer List
Table 64. Global Veterinary Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Veterinary Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Veterinary Biologics Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Veterinary Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Veterinary Biologics Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Veterinary Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Veterinary Biologics Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Veterinary Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Veterinary Biologics Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Veterinary Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Veterinary Biologics Product Portfolios and Specifications
Table 80. Merck Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Zoetis Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 84. Zoetis Veterinary Biologics Product Portfolios and Specifications
Table 85. Zoetis Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Zoetis Main Business
Table 87. Zoetis Latest Developments
Table 88. Boehringer Ingelheim Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Veterinary Biologics Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Ceva Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Veterinary Biologics Product Portfolios and Specifications
Table 95. Ceva Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Ceva Main Business
Table 97. Ceva Latest Developments
Table 98. CAHIC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Veterinary Biologics Product Portfolios and Specifications
Table 100. CAHIC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. HVRI Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. HVRI Veterinary Biologics Product Portfolios and Specifications
Table 105. HVRI Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. HVRI Main Business
Table 107. HVRI Latest Developments
Table 108. Ringpu Biology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Ringpu Biology Veterinary Biologics Product Portfolios and Specifications
Table 110. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Ringpu Biology Main Business
Table 112. Ringpu Biology Latest Developments
Table 113. Yebio Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. Yebio Veterinary Biologics Product Portfolios and Specifications
Table 115. Yebio Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Yebio Main Business
Table 117. Yebio Latest Developments
Table 118. DHN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. DHN Veterinary Biologics Product Portfolios and Specifications
Table 120. DHN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. DHN Main Business
Table 122. DHN Latest Developments
Table 123. WINSUN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 124. WINSUN Veterinary Biologics Product Portfolios and Specifications
Table 125. WINSUN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. WINSUN Main Business
Table 127. WINSUN Latest Developments
Table 128. Elanco/Eli Lilly Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 129. Elanco/Eli Lilly Veterinary Biologics Product Portfolios and Specifications
Table 130. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Elanco/Eli Lilly Main Business
Table 132. Elanco/Eli Lilly Latest Developments
Table 133. Virbac Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 134. Virbac Veterinary Biologics Product Portfolios and Specifications
Table 135. Virbac Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Virbac Main Business
Table 137. Virbac Latest Developments
Table 138. Jinyu Bio-Technology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 139. Jinyu Bio-Technology Veterinary Biologics Product Portfolios and Specifications
Table 140. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Jinyu Bio-Technology Main Business
Table 142. Jinyu Bio-Technology Latest Developments
Table 143. ChengDu Tecbond Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 144. ChengDu Tecbond Veterinary Biologics Product Portfolios and Specifications
Table 145. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. ChengDu Tecbond Main Business
Table 147. ChengDu Tecbond Latest Developments
Table 148. CAVAC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 149. CAVAC Veterinary Biologics Product Portfolios and Specifications
Table 150. CAVAC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. CAVAC Main Business
Table 152. CAVAC Latest Developments
Table 153. Kyoto Biken Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoto Biken Veterinary Biologics Product Portfolios and Specifications
Table 155. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Kyoto Biken Main Business
Table 157. Kyoto Biken Latest Developments
Table 158. FATRO Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 159. FATRO Veterinary Biologics Product Portfolios and Specifications
Table 160. FATRO Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. FATRO Main Business
Table 162. FATRO Latest Developments
Table 163. Vaksindo Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 164. Vaksindo Veterinary Biologics Product Portfolios and Specifications
Table 165. Vaksindo Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Vaksindo Main Business
Table 167. Vaksindo Latest Developments
Table 168. Bio-Labs Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 169. Bio-Labs Veterinary Biologics Product Portfolios and Specifications
Table 170. Bio-Labs Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Bio-Labs Main Business
Table 172. Bio-Labs Latest Developments
Table 173. Avimex Animal Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors
Table 174. Avimex Animal Veterinary Biologics Product Portfolios and Specifications
Table 175. Avimex Animal Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Avimex Animal Main Business
Table 177. Avimex Animal Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Biologics
Figure 2. Veterinary Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Biologics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Veterinary Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccines
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Veterinary Biologics Sales Market Share by Type in 2022
Figure 12. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Figure 13. Veterinary Biologics Consumed in Llivestock
Figure 14. Global Veterinary Biologics Market: Llivestock (2018-2023) & (K Units)
Figure 15. Veterinary Biologics Consumed in Equine
Figure 16. Global Veterinary Biologics Market: Equine (2018-2023) & (K Units)
Figure 17. Veterinary Biologics Consumed in Other
Figure 18. Global Veterinary Biologics Market: Other (2018-2023) & (K Units)
Figure 19. Global Veterinary Biologics Sales Market Share by Application (2022)
Figure 20. Global Veterinary Biologics Revenue Market Share by Application in 2022
Figure 21. Veterinary Biologics Sales Market by Company in 2022 (K Units)
Figure 22. Global Veterinary Biologics Sales Market Share by Company in 2022
Figure 23. Veterinary Biologics Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Veterinary Biologics Revenue Market Share by Company in 2022
Figure 25. Global Veterinary Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Veterinary Biologics Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Veterinary Biologics Sales 2018-2023 (K Units)
Figure 28. Americas Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 29. APAC Veterinary Biologics Sales 2018-2023 (K Units)
Figure 30. APAC Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 31. Europe Veterinary Biologics Sales 2018-2023 (K Units)
Figure 32. Europe Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Veterinary Biologics Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 35. Americas Veterinary Biologics Sales Market Share by Country in 2022
Figure 36. Americas Veterinary Biologics Revenue Market Share by Country in 2022
Figure 37. Americas Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 38. Americas Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 39. United States Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Veterinary Biologics Sales Market Share by Region in 2022
Figure 44. APAC Veterinary Biologics Revenue Market Share by Regions in 2022
Figure 45. APAC Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 46. APAC Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 47. China Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Veterinary Biologics Sales Market Share by Country in 2022
Figure 55. Europe Veterinary Biologics Revenue Market Share by Country in 2022
Figure 56. Europe Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 57. Europe Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 58. Germany Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Veterinary Biologics Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Veterinary Biologics Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 67. Egypt Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Veterinary Biologics in 2022
Figure 73. Manufacturing Process Analysis of Veterinary Biologics
Figure 74. Industry Chain Structure of Veterinary Biologics
Figure 75. Channels of Distribution
Figure 76. Global Veterinary Biologics Sales Market Forecast by Region (2024-2029)
Figure 77. Global Veterinary Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Veterinary Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Veterinary Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Veterinary Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Veterinary Biologics Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Veterinary Biologics
Figure 2. Veterinary Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Biologics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Veterinary Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccines
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Veterinary Biologics Sales Market Share by Type in 2022
Figure 12. Global Veterinary Biologics Revenue Market Share by Type (2018-2023)
Figure 13. Veterinary Biologics Consumed in Llivestock
Figure 14. Global Veterinary Biologics Market: Llivestock (2018-2023) & (K Units)
Figure 15. Veterinary Biologics Consumed in Equine
Figure 16. Global Veterinary Biologics Market: Equine (2018-2023) & (K Units)
Figure 17. Veterinary Biologics Consumed in Other
Figure 18. Global Veterinary Biologics Market: Other (2018-2023) & (K Units)
Figure 19. Global Veterinary Biologics Sales Market Share by Application (2022)
Figure 20. Global Veterinary Biologics Revenue Market Share by Application in 2022
Figure 21. Veterinary Biologics Sales Market by Company in 2022 (K Units)
Figure 22. Global Veterinary Biologics Sales Market Share by Company in 2022
Figure 23. Veterinary Biologics Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Veterinary Biologics Revenue Market Share by Company in 2022
Figure 25. Global Veterinary Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Veterinary Biologics Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Veterinary Biologics Sales 2018-2023 (K Units)
Figure 28. Americas Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 29. APAC Veterinary Biologics Sales 2018-2023 (K Units)
Figure 30. APAC Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 31. Europe Veterinary Biologics Sales 2018-2023 (K Units)
Figure 32. Europe Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Veterinary Biologics Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Veterinary Biologics Revenue 2018-2023 ($ Millions)
Figure 35. Americas Veterinary Biologics Sales Market Share by Country in 2022
Figure 36. Americas Veterinary Biologics Revenue Market Share by Country in 2022
Figure 37. Americas Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 38. Americas Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 39. United States Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Veterinary Biologics Sales Market Share by Region in 2022
Figure 44. APAC Veterinary Biologics Revenue Market Share by Regions in 2022
Figure 45. APAC Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 46. APAC Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 47. China Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Veterinary Biologics Sales Market Share by Country in 2022
Figure 55. Europe Veterinary Biologics Revenue Market Share by Country in 2022
Figure 56. Europe Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 57. Europe Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 58. Germany Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Veterinary Biologics Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Veterinary Biologics Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Veterinary Biologics Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Veterinary Biologics Sales Market Share by Application (2018-2023)
Figure 67. Egypt Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Veterinary Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Veterinary Biologics in 2022
Figure 73. Manufacturing Process Analysis of Veterinary Biologics
Figure 74. Industry Chain Structure of Veterinary Biologics
Figure 75. Channels of Distribution
Figure 76. Global Veterinary Biologics Sales Market Forecast by Region (2024-2029)
Figure 77. Global Veterinary Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Veterinary Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Veterinary Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Veterinary Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Veterinary Biologics Revenue Market Share Forecast by Application (2024-2029)
